S. Rota

Aromatase inhibitors in premenopause: Great expectations fulfilled?

A. Santoro, R. Torrisi, G. Masci, 2016, Critical reviews in oncology/hematology.

Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients

E. Clementi, G. Casazza, N. La Verde, 2021, The Pharmacogenomics Journal.

Attitudes on fertility issues in breast cancer patients: an Italian survey

N. Biglia, F. Peccatori, M. D'Alonzo, 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi’s sarcoma: a real-life study

D. De Francesco, N. La Verde, S. Piva, 2021, Journal of chemotherapy.

The emotional impact of the COVID-19 outbreak on cancer outpatients and their caregivers: results of a survey conducted in the midst of the Italian pandemic

E. Rulli, F. Galli, N. La Verde, 2021, Supportive Care in Cancer.

A proposal of a “ready to use” COVID-19 control strategy in an Oncology ward: Utopia or reality?

S. Merli, A. Brambilla, N. La Verde, 2020, Critical Reviews in Oncology/Hematology.

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer

C. Hudis, L. Norton, P. Morris, 2018, Clinical Breast Cancer.

Controversies in clinicopathological characteristics and treatment strategies of male breast cancer: A review of the literature.

A. Santoro, G. Bottai, W. Gatzemeier, 2017, Critical reviews in oncology/hematology.

Potential impact of the 70-gene signature in the choice of adjuvant systemic treatment for ER positive, HER2 negative tumors: a single institution experience.

E. Morenghi, A. Sagona, W. Gatzemeier, 2013, Breast.

Fight against cancer in Italy: What patients, caregivers and healthy citizens think about care delivery from National Health System.

N. La Verde, S. Piva, A. Mancuso, 2022, European journal of cancer care.

Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial.

S. Barni, R. Labianca, D. Amadori, 2021, European journal of cancer.